IL25 and neoplasm: Mechanistically, ILC2-derived IL-4 and IL-13 in response to IL-25 signaling activated tumour M-MDSCs derived from Apc1322T/+ mice to express Arginase 1 (Arg1) and suppress CD8+ T cells (81) .